6.72
Novonesis (Novozymes) B
Metrics score locked — part of Premium
FY19
FY20
FY21
FY24
FY25
FY19 – FY25
Assets
(positive)
Change from FY19 to FY25
billions EUR
FY19:
FY20:
6.43
FY21:
7.54
FY24:
1.88
FY25:
1.98
(positive)
Change from FY19 to FY25
billions EUR
FY19:
9.55
FY20:
8.93
FY21:
9.31
FY24:
13.3
FY25:
14.4
Total assets
Change from FY19 to FY25
billions EUR
FY19:
16.3
FY20:
15.4
FY21:
16.8
FY24:
15.2
FY25:
16.3
Liabilities & Equity
(negative)
Change from FY19 to FY25
billions EUR
FY19:
4.07
FY20:
1.24
FY21:
1.61
FY24:
1.09
FY25:
2.74
(negative)
Change from FY19 to FY25
billions EUR
FY19:
3.16
FY20:
3.79
FY21:
0.90
FY24:
2.93
FY25:
2.75
(positive)
Change from FY19 to FY25
billions EUR
FY19:
11.4
FY20:
11.8
FY21:
11.9
FY24:
11.2
FY25:
10.9
Total liabilities & equity
Change from FY24 to FY25
billions EUR
FY19:
–
FY20:
–
FY21:
–
FY24:
15.2
FY25:
16.3
All amounts in billions EUR